OneMedNet的内部采购与季度亏损和销售定额股票同时发生。 Insider purchases at OneMedNet coincide with quarterly loss and sell-rated stock.

Interr Jeffrey Yu在2025年8月至9月期间以每股0.69美元至1.03美元的价格购买了OneMedNet(ONMD)的200 000多股股份,其所有权增加到696万股左右。 Insider Jeffrey Yu purchased over 200,000 shares of OneMedNet (ONMD) between August and September 2025 at prices between $0.69 and $1.03 per share, increasing his ownership to about 6.96 million shares. 2025年,Thomas Kosasa局长也多次购买股票,包括8月581 395股,9月6 000股,这大大增加了他的股份。 Director Thomas Kosasa also made multiple purchases in 2025, including 581,395 shares in August and 6,000 in September, boosting his stake significantly. 该公司报告,11月14日,季度每股损失0.01美元,收入180 000美元。 The company reported a quarterly loss of $0.01 per share and $180,000 in revenue on November 14. 截至2025年11月26日, OneMedNet的股票交易额为1.42美元,市场上限为7 243万美元。 As of November 26, 2025, OneMedNet’s stock traded at $1.42 with a market cap of $72.43 million. 分析师保持“销售”共识评级,指出尽管该公司采用AI驱动的临床成像解决方案,但资金持续损失和前景不确定。 Analysts maintain a "sell" consensus rating, citing ongoing financial losses and uncertain prospects despite the company’s AI-driven clinical imaging solutions.